Cladribine, Idarubicin, Cytarabine, and Quizartinib Trial
Phase 1/2
80
about 8.2 years
18+
1 site in TX
What this study is about
This trial is testing the safety and effectiveness of cladribine, idarubicin, cytarabine, and quizartinib in treating acute myeloid leukemia or high-risk myelodysplastic syndrome. The treatment may involve medication to stop cancer cell growth.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cladribine
- 2.Take Cytarabine
- 3.Take Idarubicin
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cladribine, cytarabine, idarubicin, quizartinib
injection, intravenous, injection (Injection), oral (Oral Tablet)
Primary: Event free survival (EFS), Incidence of adverse events
Secondary: Disease free survival (DFS), Overall survival (OS)
Oncology, Musculoskeletal